After-Hours Stock Movers:

QEP Resources, Inc. (NYSE: QEP) 26.9% HIGHER; announced today that it has entered into an amendment to its existing credit agreement with Wells Fargo Bank, National Association, and other lenders (the Credit Agreement).

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) 23% HIGHER; announced that its supplemental New Drug Application (sNDA) for GOCOVRI as a treatment for OFF episodes in Parkinson’s disease (PD) patients receiving levodopa-based therapy has been accepted for review by the U.S. Food and Drug Administration (FDA). The anticipated Prescription Drug User Fee Act (PDUFA) action date is February 1, 2021.

Slack (NYSE: WORK) 16.4% LOWER; reported Q1 EPS of ($0.02), $0.04 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $201.7 million versus the consensus estimate of $188.12 million. Slack sees Q2 2021 EPS of ($0.04)-($0.03), versus the consensus of ($0.06). Slack sees Q2 2021 revenue of $206-209 million, versus the consensus of $199.8 million. Slack sees FY2021 EPS of ($0.19)-($0.17), versus the consensus of ($0.20). Slack sees FY2021 revenue of $855-870 million, versus the consensus of $860.3 million. Slack is withdrawing guidance for the full fiscal year 2021 Calculated Billings.

Menlo Therapeutics Inc. (Nasdaq: MNLO) 12.2% LOWER; announced that it intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering

Extreme Networks (NASDAQ: EXTR) 11.2% HIGHER; Director, Edward Kennedy, bought 122,100 shares from 06/02-06/03 at prices from $3.95-$4.16.

Domo, Inc. (NASDAQ: DOMO) 7.5% HIGHER; reported Q1 EPS of ($0.65), $0.26 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $48.6 million versus the consensus estimate of $45.65 million. Domo, Inc. sees Q2 2021 EPS of ($0.52)-($0.48), versus the consensus of ($0.60). Domo, Inc. sees Q2 2021 revenue of $48.5-49.5 million, versus the consensus of $45.83 million. Domo, Inc. sees FY2021 EPS of ($2.06)-($1.96), versus the consensus of ($2.49). Domo, Inc. sees FY2021 revenue of $194-200 million, versus the consensus of $186.88 million.

Cooper Cos. (NYSE: COO) 6% LOWER; reported Q2 EPS of $1.51, $0.78 worse than the analyst estimate of $2.29. Revenue for the quarter came in at $524.9 million versus the consensus estimate of $591.58 million. Given the uncertainty on near-term financial results caused by the COVID-19 pandemic, the company is no longer providing fiscal year 2020 guidance.

PagerDuty, Inc. (NYSE: PD) 4.4% LOWER; reported Q1 EPS of ($0.04), $0.05 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $49.8 million versus the consensus estimate of $47.99 million. PagerDuty, Inc. sees Q2 2021 EPS of ($0.07)-($0.06), versus the consensus of ($0.08). PagerDuty, Inc. sees Q2 2021 revenue of $50-51 million, versus the consensus of $49.79 million. PagerDuty, Inc. sees FY2021 EPS of ($0.30)-($0.25), versus the consensus of ($0.31). PagerDuty, Inc. sees FY2021 revenue of $204-213 million, versus the consensus of $206.69 million.

Veeco Instruments Inc. (NASDAQ: VECO) 4.3% HIGHER; Oppenheimer initiates coverage onwith a Outperform rating and a price target of $18.00.

Zumiez, Inc. (NASDAQ: ZUMZ) 4.1% LOWER; reported Q1 EPS of ($0.84), $0.43 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $137.8 million versus the consensus estimate of $152.12 million.

Gap, Inc. (NYSE: GPS) 4% LOWER; reported Q1 EPS of ($2.51), versus $0.60 reported last year. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.3 billion.

DocuSign Inc. (NASDAQ: DOCU) 3% HIGHER; reported Q1 EPS of $0.12, $0.02 better than the analyst estimate of $0.10. Revenue for the quarter came in at $297 million versus the consensus estimate of $281.12 million. DocuSign Inc. sees Q2 2021 revenue of $316-320 million, versus the consensus of $302.98 million. DocuSign Inc. sees FY2021 revenue of $1.313-1.317 billion, versus the consensus of $1.26 billion.